Black Diamond Therapeutics, Inc. (BDTX)
1.78
-0.08
(-4.30%)
USD |
NASDAQ |
Oct 30, 16:00
1.77
-0.01
(-0.56%)
After-Hours: 20:00
Black Diamond Therapeutics Market Cap : 102.25M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 102.25M |
| October 29, 2026 | 106.85M |
| October 28, 2026 | 105.13M |
| October 27, 2026 | 100.53M |
| October 26, 2026 | 97.08M |
| October 23, 2026 | 108.00M |
| October 22, 2026 | 119.49M |
| October 21, 2026 | 119.49M |
| October 20, 2026 | 118.91M |
| October 19, 2026 | 103.98M |
| October 16, 2026 | 98.81M |
| October 15, 2026 | 99.96M |
| October 14, 2026 | 97.66M |
| October 13, 2026 | 96.51M |
| October 12, 2026 | 101.68M |
| October 09, 2026 | 105.13M |
| October 08, 2026 | 103.98M |
| October 07, 2026 | 105.13M |
| October 06, 2026 | 103.40M |
| October 05, 2026 | 111.45M |
| October 02, 2026 | 108.57M |
| October 01, 2026 | 108.00M |
| September 30, 2026 | 108.29M |
| September 29, 2026 | 107.42M |
| September 28, 2026 | 105.13M |
| Date | Value |
|---|---|
| September 25, 2026 | 108.00M |
| September 24, 2026 | 108.57M |
| September 23, 2026 | 109.15M |
| September 22, 2026 | 113.74M |
| September 21, 2026 | 112.02M |
| September 18, 2026 | 112.59M |
| September 17, 2026 | 110.87M |
| September 16, 2026 | 111.45M |
| September 15, 2026 | 113.17M |
| September 14, 2026 | 116.62M |
| September 11, 2026 | 113.74M |
| September 10, 2026 | 112.59M |
| September 09, 2026 | 120.64M |
| September 08, 2026 | 120.64M |
| September 04, 2026 | 121.79M |
| September 03, 2026 | 120.64M |
| September 02, 2026 | 122.94M |
| September 01, 2026 | 117.19M |
| August 31, 2026 | 120.64M |
| August 28, 2026 | 128.11M |
| August 27, 2026 | 130.40M |
| August 26, 2026 | 130.40M |
| August 25, 2026 | 128.68M |
| August 24, 2026 | 123.80M |
| August 21, 2026 | 126.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lineage Cell Therapeutics, Inc. | 252.91M |
| Armata Pharmaceuticals, Inc. | 121.84M |
| Voyager Therapeutics, Inc. | 105.39M |
| Invivyd, Inc. | 171.46M |
| Elicio Therapeutics, Inc. | 36.79M |
Market Cap Related Metrics
| Price to Book Value | 1.064 |
| Price | 1.78 |
| Earnings Yield | -41.84% |